Guidant Defibrillator Deal Expanded To $240M
After additional patients stepped forward claiming they had been injured from the implantable heart defibrillators, the medical device maker and the plaintiffs expanded their July deal. That deal would have had Boston Scientific paying $195 million to settle over 5,600 MDL and state court claims.
“This amended agreement is great news for the patient...
To view the full article, register now.